26-28 March, 2018
Berlin, Germany

Europe’s Leading Antibody-Drug Conjugate Summit

World ADC curates the latest ADC science, clinical data and lessons learned to enable you to develop more clinically effective ADC compounds.

Covering the A-Z of ADCs from early discovery to manufacturing the 8th Annual World ADC Berlin will give you an incomparable amount of ADC insight, new data and experiences learned to power the next 12 months of your ADC research.

Annually, over 300 drug developers across 140+ key organisations converge at this conference to build new business relationships and further cement partnerships.

This year, the forum served up 64 talks distilling the latest research and novel data on; designing and synthesising payloads with novel mechanisms of action, improving preclinical to clinical translation and scaling up from clinical to commercial scale manufacturing.

We are already busy building next year’s programme. If you are interested in partnering, speaking or attending World ADC Europe simply email us and we’ll be in touch.

“The World ADC meeting was again a great platform for scientific exchange with networking at its best.” Boehringer Ingelheim

“7th World ADC conference is a perfect platform for budding researchers like me. This meeting is really a golden standard for the current development in the field of ADCs and Immunoncology. I would like to recommend all my colleagues/co-workers to be a part of this event next year” The University of Georgia

“The conference was very well organized and very informative. It brought together researchers across the world who are active in ADC space to share their experiences including successes and failures. Great speed networking events” Pfizer

Join your Peers Infographic v2
Beacon button v 2



Media Partner